Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Okun

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Tsitologiia|August 1, 1989
[Cytoskeletal regulation of the sensitivity of brain synaptosomes to the depolarizing action of veratrine]A A Rakovich, S L Aksentsev, I M Okun', et al.
General Physiology and Biophysics|December 1, 1992
Sensitivity of the brain synaptosomal membrane Mg(2+)-ATPase activity to arachidonic acid is under control of the Na+,K(+)-ATPase stateI M Okun, T I Lyskova, S L Aksentsev, et al.
Biofizika|March 1, 1992
[Effect of temperature on polarity of an annular and bilayer synaptic membrane lipid]S G Samoĭlenko, I M Okun', S L Aksentsev, et al.
Biofizika|March 1, 1988
[Regulation of mechanical stability of erythrocytes by serum immunoglobulins]R D Adzerikho, I M Okun', S L Aksentsev, et al.
Inorganic Chemistry|October 14, 2003
Cupric decamolybdodivanadophosphate. A coordination polymer heterogeneous catalyst for rapid, high conversion, high selectivity sulfoxidation using the ambient environmentNelya M Okun, Travis M Anderson, Kenneth I Hardcastle, et al.
Biofizika|November 1, 1980
[Do anesthetics cause conformational changes in the majority of proteins in synaptic membranes?]A A Rakovich, I M Okun', S L Aksentsev, et al.
Fiziologicheskii Zhurnal|September 1, 1990
[Structural reorganization of the brain synaptic membranes and aging]S V Konev, S L Aksentsev, I M Okun', et al.
Current Alzheimer Research|November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal ModelsAlexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2016
Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasisN M Mostafa, A M Nader, P Noertersheuser, et al.
The British Journal of Dermatology|April 17, 2010
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasisR G Langley, B E Strober, Y Gu, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Tsitologiia|August 1, 1989
[Cytoskeletal regulation of the sensitivity of brain synaptosomes to the depolarizing action of veratrine]A A Rakovich, S L Aksentsev, I M Okun', et al.
General Physiology and Biophysics|December 1, 1992
Sensitivity of the brain synaptosomal membrane Mg(2+)-ATPase activity to arachidonic acid is under control of the Na+,K(+)-ATPase stateI M Okun, T I Lyskova, S L Aksentsev, et al.
Biofizika|March 1, 1992
[Effect of temperature on polarity of an annular and bilayer synaptic membrane lipid]S G Samoĭlenko, I M Okun', S L Aksentsev, et al.
Biofizika|March 1, 1988
[Regulation of mechanical stability of erythrocytes by serum immunoglobulins]R D Adzerikho, I M Okun', S L Aksentsev, et al.
Inorganic Chemistry|October 14, 2003
Cupric decamolybdodivanadophosphate. A coordination polymer heterogeneous catalyst for rapid, high conversion, high selectivity sulfoxidation using the ambient environmentNelya M Okun, Travis M Anderson, Kenneth I Hardcastle, et al.
Biofizika|November 1, 1980
[Do anesthetics cause conformational changes in the majority of proteins in synaptic membranes?]A A Rakovich, I M Okun', S L Aksentsev, et al.
Fiziologicheskii Zhurnal|September 1, 1990
[Structural reorganization of the brain synaptic membranes and aging]S V Konev, S L Aksentsev, I M Okun', et al.
Current Alzheimer Research|November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal ModelsAlexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2016
Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasisN M Mostafa, A M Nader, P Noertersheuser, et al.
The British Journal of Dermatology|April 17, 2010
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasisR G Langley, B E Strober, Y Gu, et al.
Pageof 11